Objectives: Breast cancer constitutes the majority of diagnosed cancers in Oman’s females, accounting for 19.2%, which prompted the introduction of a breast cancer screening programme into the Omani healthcare system. There are rising international concerns about the effectiveness of mammography as a screening tool and its psychological impact. The current study aimed to determine the social, emotional and physical dysfunction caused by the waiting time from the day of scheduling the appointment until the day of screening and explore associated risk factors. Methods: This cross-sectional study was conducted between March and December 2017 at Khoula Hospital, Muscat, Oman, using a two-part self-administered questionnaire. Part one of the questionnaire collected clinical and demographic data. Part two consisted of the Psychological Consequences Questionnaire (PCQ) and focused on psychological consequences, measuring the effect of mammographic screening on emotional, physical and social functions. Results: A total of 300 women aged ≥40 years old participated in this study (response rate: 100%). Results revealed that there was a minimal negative psychological impact from screening using mammograms. All PCQ domains were significantly impacted for participants who reported a family history of cancer (P = 0.007). The social score was significantly higher among women between 40–50 years old (P = 0.008). Scores of emotional and social functions were significantly affected by participants’ employment status; employed women were more affected than those who were not (P = 0.043 and 0.012, respectively). However, women’s levels of literacy did not affect any of the domains. Conclusion: The psychosocial impact of the waiting period between scheduling and undergoing mammography screening was minimal in the current sample. Future research should evaluate the psychosocial impact on patients at different recall times.Keywords: Breast Cancer; Mammography; Psychological Factors; Depression; Anxiety; Oman.

BACKGROUND: Previous research has highlighted potential associations between anemia, diabetes, and worsening kidney disease. The aim of this study, therefore, was to determine the prevalence of anemia in patients with both chronic kidney disease (CKD) and Type 2 diabetes mellitus (T2DM) at a primary care center in Oman. MATERIALS AND METHODS: A cross-sectional study was conducted at the Primary Care Clinic of Sultan Qaboos University Hospital, Muscat, Oman. All patients with established diagnoses of CKD and T2DM who attended appointments at the clinic in 2020 and 2021 were included. Data concerning the patients’ sociodemographic characteristics, medical history, clinical findings, and laboratory results during past six months were retrieved from the hospital’s information system. Patients were contacted via telephone for clarification in the event of any missing data. SPSS version 23 was used for Statistical analyses of the data. Frequencies and percentages were used to present categorical variables. Chi-squared tests were used to determine association between anemia and demographic and clinical variables. RESULTS: A total of 300 patients with T2DM and CKD were included in the study; 52% were male, 54.3% were 51–65 years of age, and majority (88%) were either overweight or obese. The majority of patients (62.7%) had Stage 1 CKD followed by Stage 2 (34.3%) and Stage 3 (3%). The total prevalence of anemia was 29.3%, with 31.4%, 24.3%, and 44.4% of Stage 1, Stage 2, and Stage 3 CKD patients being anemic, respectively. The frequency of anemia was significantly higher in female than male patients (41.7% vs. 17.9%; P < 0.001). No associations were observed between anemia status and other sociodemographic or clinical characteristics. CONCLUSION: The prevalence of anemia in CKD and T2DM primary care patients in Oman was 29.3%, with gender as the only factor significantly associated with anemia status. Routine screening of anemia in diabetic nephropathy patients is highly recommended.